Möchten Sie immer auf dem neuesten Stand bleiben?

Austin, April 13, 2026 (GLOBE NEWSWIRE) -- The Event Stream Processing Market size reached USD 3.41 Billion in 2025 and is anticipated to touch USD 16.08 Billion by 2035, exhibiting a growth rate...

SHANGHÁI, April 13, 2026 (GLOBE NEWSWIRE) -- CHINAPLAS 2026 se celebrará del 21 al 24 de abril en el Centro Nacional de Exposiciones y Convenciones (NECC) de Shanghái. Bajo el tema...

Växjö, Sverige, 13:e april 2026 * * * JLT Mobile Computers, ledande leverantör av stryktåliga datorer för krävande miljöer, släpper idag sin årsredovisning för verksamhetsåret 2025. Periodens...

TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, including ORR by RECIST V1.1 and Tumor Volume Score (TVS), and clinically...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly...

BASEL, Switzerland, April 13, 2026 (GLOBE NEWSWIRE) -- BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and...

The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple sclerosis.1This minimally invasive blood test enables...

Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants L'approbation dans l'urticaire chronique spontanée...

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is...

CAPHRA supports Bangladesh’s review of its sweeping 2025 ban on vaping and other emerging nicotine products as a chance to save lives.